BIOT

Equity

L&G PHARMA BREAKTHROUGH UCITS ETF

TER (bps):

49

AUM (USD m):

19

ISIN:

IE00BF0H7608

Domicile:

Ireland

Share Class Currency:

USD

ESG:

No

Geographical Focus:

Global

As of:

20 May 2024

Climate Fund:

No

Benchmark

The Solactive Pharma Breakthrough Value Index aims to track the performance of a basket of stocks of companies that are actively engaged in the research, development and/or manufacturing of orphan drugs. it uses a two-fold approach that is primarily based on the trend in the valuation of a company’s orphan drug portfolio and its overall revenue forecasts. The Index selects stocks that meet certain size and liquidity requirements.

PERFORMANCE

Powered byhttps://www.etfbook.com/ logo